Literature DB >> 17154757

Deconstructing therapy outcome measurement with Rasch analysis of a measure of general clinical distress: the Symptom Checklist-90-Revised.

Robert Elliott1, Christine M Fox, Svetlana A Beltyukova, Gregory E Stone, Jennifer Gunderson, Xi Zhang.   

Abstract

Rasch analysis was used to illustrate the usefulness of item-level analyses for evaluating a common therapy outcome measure of general clinical distress, the Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1994). Using complementary therapy research samples, the instrument's 5-point rating scale was found to exceed clients' ability to make reliable discriminations and could be improved by collapsing it into a 3-point version (combining scale points 1 with 2 and 3 with 4). This revision, in addition to removing 3 misfitting items, increased person separation from 4.90 to 5.07 and item separation from 7.76 to 8.52 (resulting in alphas of .96 and .99, respectively). Some SCL-90-R subscales had low internal consistency reliabilities; SCL-90-R items can be used to define one factor of general clinical distress that is generally stable across both samples, with two small residual factors. (c) 2006 APA, all rights reserved.

Entities:  

Mesh:

Year:  2006        PMID: 17154757     DOI: 10.1037/1040-3590.18.4.359

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  9 in total

1.  A longitudinal study of self-reported psychopathology in early ecstasy and amphetamine users.

Authors:  Daniel Wagner; Philip Koester; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Martin Hellmich; Joerg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2014-08-27       Impact factor: 4.530

2.  A study of the dimensionality and measurement precision of the SCL-90-R using item response theory.

Authors:  Muirne C S Paap; Rob R Meijer; Jan Van Bebber; Geir Pedersen; Sigmund Karterud; Frøydis M Hellem; Ira R Haraldsen
Journal:  Int J Methods Psychiatr Res       Date:  2011-08-03       Impact factor: 4.035

3.  What counts as effective genetic counselling for presymptomatic testing in late-onset disorders? A study of the consultand's perspective.

Authors:  Lídia Guimarães; Jorge Sequeiros; Heather Skirton; Milena Paneque
Journal:  J Genet Couns       Date:  2013-01-07       Impact factor: 2.537

4.  Perceived Epidemic Risk and Depression Symptoms during the COVID-19 Pandemic: The Mediating Role of Security and the Moderation Role of Perceived Discrimination.

Authors:  Yunjun Hu; Lingling Shu; Huilin Zhang; Chen Wang; Chengfu Yu; Guanyu Cui
Journal:  Int J Environ Res Public Health       Date:  2022-06-09       Impact factor: 4.614

5.  Psychological factors associated with development of TMD: the OPPERA prospective cohort study.

Authors:  Roger B Fillingim; Richard Ohrbach; Joel D Greenspan; Charles Knott; Luda Diatchenko; Ronald Dubner; Eric Bair; Cristina Baraian; Nicole Mack; Gary D Slade; William Maixner
Journal:  J Pain       Date:  2013-12       Impact factor: 5.820

Review 6.  Do patients' symptoms and interpersonal problems improve in psychotherapeutic hospital treatment in Germany? A systematic review and meta-analysis.

Authors:  Sarah Liebherz; Sven Rabung
Journal:  PLoS One       Date:  2014-08-20       Impact factor: 3.240

7.  Prevalence of psychological symptoms among Ebola survivors and healthcare workers during the 2014-2015 Ebola outbreak in Sierra Leone: a cross-sectional study.

Authors:  Dong Ji; Ying-Jie Ji; Xue-Zhang Duan; Wen-Gang Li; Zhi-Qiang Sun; Xue-Ai Song; Yu-Hua Meng; Hong-Mei Tang; Fang Chu; Xiao-Xia Niu; Guo-Feng Chen; Jin Li; Hui-Juan Duan
Journal:  Oncotarget       Date:  2017-02-21

8.  The negative affect repair questionnaire: factor analysis and psychometric evaluation in three samples.

Authors:  Anne Scherer; Nicole Eberle; Maren Boecker; Claus Vögele; Siegfried Gauggel; Thomas Forkmann
Journal:  BMC Psychiatry       Date:  2013-01-09       Impact factor: 3.630

9.  Measuring Mental Health Recovery: An Application of Rasch Modeling to the Consumer Recovery Measure.

Authors:  Kathryn Kd Lusczakoski; P Antonio Olmos-Gallo; William Milnor; Christopher J McKinney
Journal:  J Behav Health Serv Res       Date:  2016-01       Impact factor: 1.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.